Startups
Expand the limits of your data
Multiomics—Harmonized. Visualized. AI informed.
LEARN MORE
End data chaos
Rapid data production for slides, posters, and publications
Data-informed trial decisions
Multiomics—Harmonized. Visualized. AI informed.
LEARN MORE
End data chaos
Rapid data production for slides, posters, and publications
Data-informed trial decisions
Overview
Location
Switzerland
Employees
11-50
Founded date
2012
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 13, 2026 | QuartzBio Secures Growth Investment From Eir Partners To Expand AI-Powered Clinical Trial Intelligence Platform | QuartzBio announced a strategic growth investment and the acquisition of a controlling interest from Eir Partners to accelerate the development of its AI-powered clinical trial intelligence platform for biopharma organizations. Financial te... |
| May 13, 2026 | BranchLab Raises $26M in Series A Funding | BranchLab, a Boulder, CO-based provider of an AI platform supporting healthcare commercialization, raised $26M in Series A funding. The round was led by McKesson Ventures, with participation from FCA Venture Partners, Sanofi Ventures, and A... |
| Oct 17, 2013 | Quartz Bio announces positive results for MegaClust platform | |
| Jul 8, 2013 | Quartz Bio supports Debiopharm Group | |
| Apr 12, 2013 | Swiss Biotech Day: meeting place for the industry |
Reviews 0
FAQ about QuartzBio
When was QuartzBio founded?
QuartzBio was founded in 2012.
What has the press written about QuartzBio?
Parsers VC has collected 6 articles mentioning QuartzBio, among them “QuartzBio Secures Growth Investment From Eir Partners To Expand AI-Powered Clinical Trial Intelligence Platform” (May 13, 2026) and “BranchLab Raises $26M in Series A Funding” (May 13, 2026).
Is QuartzBio still active?
Yes, QuartzBio is active; its latest activity on Parsers VC dates from May 13, 2026.